The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria

NCT00346606 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Urticaria
Urticaria

Interventions

DRUG: Denosin® and Xyzal®

Sponsor

Lotus Pharmaceutical